| Literature DB >> 27669219 |
Jiying Wang1,2, Yanping Wang3, Haifei Wang4, Jianfeng Guo5, Huaizhong Wang6, Ying Wu7, Jianfeng Liu8.
Abstract
MicroRNAs (miRNAs) are one family of small noncoding RNAs that function to modulate the activity of specific mRNA targets in animals. To understand the role of miRNAs in regulating genes involved in the host immune response to RNA viruses, we profiled and characterized the miRNAs of swine peripheral blood mononuclear cells (PBMC) stimulated with poly I:C, a synthetic dsRNA analog, by miRNA-sequencing (miRNA-seq). We identified a total of 905 miRNAs, of which 503 miRNAs were firstly exploited herein with no annotation in the latest miRBase 21.0. Expression analysis demonstrated that poly I:C stimulation can elicit significantly differentially expressed (DE) miRNAs in Dapulian (n = 20), one Chinese indigenous breed, as well as Landrace (n = 23). By integrating the mRNA expression profiles of the same sample with miRNA profiles, we carried out function analyses of the target genes of these DE miRNAs, with the results indicating that target genes were most enriched in some immune-related pathways and gene ontology (GO) terms, suggesting that DE miRNAs play an important role in the regulation of host to poly I:C stimulation. Furthermore, we also detected 43 and 61 significantly DE miRNAs between the two breeds in the control sample groups and poly I:C stimulation groups, respectively, which may be involved in regulation of the different characteristics of the two breeds. This study describes for the first time the PBMC miRNA transcriptomic response to poly I:C stimulation in pigs, which not only contributes to a broad view of the pig miRNAome but improves our understanding of miRNA function in regulating host immune response to RNA viruses.Entities:
Keywords: PBMC; miRNA-seq; pigs; poly I:C; target genes
Mesh:
Substances:
Year: 2016 PMID: 27669219 PMCID: PMC5085634 DOI: 10.3390/ijms17101601
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The length distribution of mappable sequences.
Figure 2Distribution of miRNAs identified in the study on the chromosomes. Blue diamonds and red rectangles mean + strand and − strand, respectively.
Figure 3Multidimensional Scaling (MDS) analysis of the control and poly I:C stimulated samples using expression of all miRNAs. Black, red, blue and green dots mean samples of DP_controll, L_controll, DP_poly I:C, and L_poly I:C, respectively.
Significant PANTHER pathways for target genes for the differentially expressed (DE) miRNAs between the poly I:C stimulation group and control group of Dapulian (DT_DC) and Landrace (LT_LC).
| PANTHER Pathways | Annotated | Dapulian (DT_DC) | Landrace (LT_LC) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Significant | Expected | Fold Enrichment | Significant | Expected | Fold Enrichment | ||||
| Angiogenesis (P00005) | 147 | 27 | 13.37 | 2.02 | 6.50 × 10−4 | 27 | 14.56 | 1.85 | 2.16 × 10−3 |
| Cholecystokinin receptor(CCKR) signaling map (P06959) | 155 | 30 | 14.1 | 2.13 | 1.43 × 10−4 | 23 | 15.35 | 1.5 | 4.00 × 10−2 |
| Epidermal growth factor (EGF) receptor signaling pathway (P00018) | 134 | 24 | 12.19 | 1.97 | 1.73 × 10−3 | 23 | 13.27 | 1.73 | 9.35 × 10−3 |
| Fibroblast growth factor (FGF) signaling pathway (P00021) | 124 | 21 | 11.28 | 1.86 | 5.97 × 10−3 | 19 | 12.28 | 1.55 | 4.47 × 10−2 |
| Parkinson disease (P00049) | 104 | 20 | 9.46 | 2.11 | 1.82 × 10−3 | 23 | 10.3 | 2.23 | 4.26 × 10−4 |
| PI3 kinase pathway (P00048) | 45 | 10 | 4.09 | 2.44 | 9.36 × 10−3 | 11 | 4.46 | 2.47 | 6.18 × 10−3 |
| Ras Pathway (P04393) | 80 | 22 | 7.28 | 3.02 | 7.76 × 10−6 | 14 | 7.92 | 1.77 | 3.17 × 10−2 |
| T cell activation (P00053) | 83 | 16 | 7.55 | 2.12 | 4.81 × 10−3 | 15 | 8.22 | 1.82 | 2.11 × 10−2 |
| Toll receptor signaling pathway (P00054) | 59 | 10 | 5.37 | 1.86 | 4.69 × 10−2 | 11 | 5.84 | 1.88 | 3.63 × 10−2 |
| Ubiquitin proteasome pathway (P00060) | 65 | 11 | 5.91 | 1.86 | 3.89 × 10−2 | 13 | 6.44 | 2.02 | 1.48 × 10−2 |
| Gonadotropin releasing hormone receptor pathway (P06664) | 223 | 41 | 20.28 | 2.02 | 3.09 × 10−5 | – | – | – | – |
| Apoptosis signaling pathway (P00006) | 129 | 24 | 11.73 | 2.05 | 1.06 × 10−3 | – | – | – | – |
| Fas signaling pathway (P00020) | 41 | 11 | 3.73 | 2.95 | 1.65 × 10−3 | – | – | – | – |
| Vascaular endothelial growth factor (VEGF) signaling pathway (P00056) | 61 | 13 | 5.55 | 2.34 | 4.71 × 10−3 | – | – | – | – |
| Integrin signaling pathway (P00034) | 153 | 24 | 13.92 | 1.72 | 8.50 × 10−3 | – | – | – | – |
| p53 pathway feedback loops 2 (P04398) | 53 | 11 | 4.82 | 2.28 | 1.06 × 10−2 | – | – | – | – |
| De novo purine biosynthesis (P02738) | 46 | 10 | 4.18 | 2.39 | 1.08 × 10−2 | – | – | – | – |
| Oxidative stress response (P00046) | 29 | 7 | 2.64 | 2.65 | 1.83 × 10−2 | – | – | – | – |
| Transforming growth factor beta(TGF-β) signaling pathway (P00052) | 90 | 15 | 8.19 | 1.83 | 2.04 × 10−2 | – | – | – | – |
| Hypoxia response via HIF activation (P00030) | 30 | 7 | 2.73 | 2.57 | 2.15 × 10−2 | – | – | – | – |
| Platelet derived growth factor (PDGF) signaling pathway (P00047) | 141 | 21 | 12.82 | 1.64 | 2.17 × 10−2 | – | – | – | – |
| Interleukin signaling pathway (P00036) | 101 | 16 | 9.19 | 1.74 | 2.56 × 10−2 | – | – | – | – |
| Inflammation mediated by chemokine and cytokine signaling pathway (P00031) | 228 | 30 | 20.74 | 1.45 | 3.19 × 10−2 | – | – | – | – |
| Heme biosynthesis (P02746) | 14 | 4 | 1.27 | 3.14 | 4.04 × 10−2 | – | – | – | – |
| Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade (P00032) | 35 | 7 | 3.18 | 2.2 | 4.35 × 10−2 | – | – | – | – |
| p53 pathway (P00059) | 92 | 14 | 8.37 | 1.67 | 4.60 × 10−2 | – | – | – | – |
| Coenzyme A biosynthesis (P02736) | 11 | – | – | – | – | 5 | 1.09 | 4.59 | 5.21 × 10−3 |
| Salvage pyrimidine ribonucleotides (P02775) | 13 | – | – | – | – | 5 | 1.29 | 3.88 | 1.02 × 10−2 |
| B cell activation (P00010) | 68 | – | – | – | – | 13 | 6.74 | 1.93 | 2.05 × 10−2 |
| General transcription regulation (P00023) | 34 | – | – | – | – | 8 | 3.37 | 2.38 | 2.19 × 10−2 |
| Lysine biosynthesis (P02751) | 6 | – | – | – | – | 3 | 0.59 | >5 | 2.25 × 10−2 |
| Insulin/insulin-like growth factor (IGF) pathway-protein kinase B signaling cascade (P00033) | 49 | – | – | – | – | 10 | 4.85 | 2.06 | 2.67 × 10−2 |
| Angiotensin II-stimulated signaling through G proteins and β-arrestin (P05911) | 30 | – | – | – | – | 7 | 2.97 | 2.36 | 3.20 × 10−2 |
| Notch signaling pathway (P00045) | 40 | – | – | – | – | 8 | 3.96 | 2.02 | 4.88 × 10−2 |
Figure 4Regulation network between DE miRNAs and their DE target genes in response to poly I:C stimulation. Yellow and blue colors mean miRNAs and target genes, respectively.
Figure 5Correlation analysis of the fold changes between qPCR and RNA-seq.